{"id":853573,"date":"2025-05-22T05:51:02","date_gmt":"2025-05-22T09:51:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/"},"modified":"2025-05-22T05:51:02","modified_gmt":"2025-05-22T09:51:02","slug":"shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/","title":{"rendered":"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">NEW YORK<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">May 22, 2025<\/span><\/span> \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0<b>West Pharmaceutical Services, Inc. (NYSE: WST).<\/b><\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" title=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" alt=\"The Gross Law Firm (PRNewsfoto\/The Gross Law Firm)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.<\/p>\n<p class=\"prntac\">CONTACT US HERE:<\/p>\n<p class=\"prntac\">\n        <a href=\"https:\/\/securitiesclasslaw.com\/securities\/west-pharmaceutical-services-inc-loss-submission-form\/?id=149537&amp;from=4\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/west-pharmaceutical-services-inc-loss-submission-form\/?id=149537&amp;from=4<\/a>\n      <\/p>\n<p>\n        <b>CLASS PERIOD: <\/b><br \/>\n        <span class=\"xn-chron\">February 16, 2023<\/span> to <span class=\"xn-chron\">February 12, 2025<\/span><\/p>\n<p>\n        <b>ALLEGATIONS: <\/b>The complaint <span>alleges<\/span> that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin HVP portfolio; (b) West&#8217;s SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Company&#8217;s profit margins due to operational inefficiencies; (c) these margin pressures created the risk of costly restructuring activities, including the Company&#8217;s exit from continuous glucose monitoring contracts with longstanding customers; and (d) as a result of the foregoing, defendants&#8217; positive statements about the Company&#8217;s business, operations, and prospects were materially false and\/or misleading or lacked a reasonable basis.<\/p>\n<p>\n        <b>DEADLINE: <span class=\"xn-chron\">July 7, 2025<\/span><\/b> Shareholders should not delay in registering for this class action. Register your information here: <a href=\"https:\/\/securitiesclasslaw.com\/securities\/west-pharmaceutical-services-inc-loss-submission-form\/?id=149537&amp;from=4\" rel=\"nofollow\">https:\/\/securitiesclasslaw.com\/securities\/west-pharmaceutical-services-inc-loss-submission-form\/?id=149537&amp;from=4<\/a><\/p>\n<p>\n        <b>NEXT STEPS FOR SHAREHOLDERS: <\/b>Once you register as a shareholder who purchased shares of WST during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is <span class=\"xn-chron\">July 7, 2025<\/span>. There is no cost or obligation to you to participate in this case.<\/p>\n<p>\n        <b>WHY GROSS LAW FIRM? <\/b>The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, <span>fraud<\/span>, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and\/or misleading statements or the omission of material information by a company lead to artificial inflation of the company&#8217;s stock. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n<p>\n        <b>CONTACT:<\/b><br \/>\n        <br \/>The Gross Law Firm<br \/>15 West 38th Street, 12th floor<br \/><span class=\"xn-location\">New York, NY<\/span>, 10018<br \/>Email: <a href=\"mailto:dg@securitiesclasslaw.com\" rel=\"nofollow\">dg@securitiesclasslaw.com<\/a><br \/>Phone: (646) 453-8903<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=NY93932&amp;sd=2025-05-22\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights--wst-302462578.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights&#8211;wst-302462578.html<\/a><\/p>\n<p>SOURCE  The Gross Law Firm<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=NY93932&amp;Transmission_Id=202505220545PR_NEWS_USPR_____NY93932&amp;DateId=20250522\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire NEW YORK , May 22, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/west-pharmaceutical-services-inc-loss-submission-form\/?id=149537&amp;from=4 CLASS PERIOD: February 16, 2023 to February 12, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-853573","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire NEW YORK , May 22, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/west-pharmaceutical-services-inc-loss-submission-form\/?id=149537&amp;from=4 CLASS PERIOD: February 16, 2023 to February 12, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across &hellip; Continue reading &quot;Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-22T09:51:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST\",\"datePublished\":\"2025-05-22T09:51:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/\"},\"wordCount\":456,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/\",\"name\":\"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"datePublished\":\"2025-05-22T09:51:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2280333\\\/The_Gross_Law_Firm_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/","og_locale":"en_US","og_type":"article","og_title":"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST - Market Newsdesk","og_description":"PR Newswire NEW YORK , May 22, 2025 \/PRNewswire\/ &#8212; The Gross Law Firm issues the following notice to shareholders of\u00a0West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https:\/\/securitiesclasslaw.com\/securities\/west-pharmaceutical-services-inc-loss-submission-form\/?id=149537&amp;from=4 CLASS PERIOD: February 16, 2023 to February 12, 2025 ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and\/or misleading statements and\/or failed to disclose that: (a) despite claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across &hellip; Continue reading \"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/","og_site_name":"Market Newsdesk","article_published_time":"2025-05-22T09:51:02+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST","datePublished":"2025-05-22T09:51:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/"},"wordCount":456,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/","name":"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights - WST - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","datePublished":"2025-05-22T09:51:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2280333\/The_Gross_Law_Firm_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/shareholders-of-west-pharmaceutical-services-inc-should-contact-the-gross-law-firm-before-july-7-2025-to-discuss-your-rights-wst\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Shareholders of West Pharmaceutical Services, Inc. Should Contact The Gross Law Firm Before July 7, 2025 to Discuss Your Rights &#8211; WST"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/853573","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=853573"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/853573\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=853573"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=853573"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=853573"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}